GLP-1 Therapies: A Potential Link to Reduced Autoimmune Complications
New research suggests GLP-1 therapies, known for treating obesity, may also be linked to fewer complications in adults with co-occurring autoimmune diseases.
New research suggests GLP-1 therapies, known for treating obesity, may also be linked to fewer complications in adults with co-occurring autoimmune diseases.